27694930|t|Low Concentration of Sodium Butyrate from Ultrabraid + NaBu suture, Promotes Angiogenesis and Tissue Remodelling in Tendon - bones Injury
27694930|a|Sodium butyrate (NaBu), a form of short-chain fatty acid (SCFA), acts classically as a potent anti-angiogenic agent in tumour angiogenesis models, some authors demonstrated that low concentrations of NaBu may contribute to healing of tendon - bone injury in part at least through promotion of tissue remodelling. Here, we investigated the effects of low -range concentrations of NaBu using in vitro and in vivo assays using angiogenesis as the primary outcome measure and the mechanisms through which it acts. We demonstrated that NaBu, alone or perfused from the UltraBraid + NaBu suture was pro-angiogenic at very low -range doses promoting migration, tube formation and cell invasion in bovine aortic endothelial cells (BAECs). Furthermore, cell exposure to low NaBu concentrations increased expression of proteins involved in angiogenic cell signalling, including p-PKCβ1, p-FAK, p-ERK1 / 2, p-NFκβ, p-PLCγ1 and p-VEGFR2. In addition, inhibitors of both VEGFR2 and PKCβ1 blocked the angiogenic response. In in vivo assays, low concentrations of NaBu induced neovascularization in sponge implants in mice, evidenced by increased numbers of vessels and haemoglobin content in these implants. The findings in this study indicate that low concentrations of NaBu could be an important compound to stimulate angiogenesis at a site where vasculature is deficient and healing is compromised.
27694930	21	36	Sodium Butyrate	T103	UMLS:C0142812
27694930	42	52	Ultrabraid	T074	UMLS:C0038969
27694930	55	59	NaBu	T103	UMLS:C0142812
27694930	60	66	suture	T074	UMLS:C0038969
27694930	77	89	Angiogenesis	T038	UMLS:C0302600
27694930	94	112	Tissue Remodelling	T038	UMLS:C1820201
27694930	116	122	Tendon	T017	UMLS:C0039508
27694930	125	137	bones Injury	T037	UMLS:C0561852
27694930	138	153	Sodium butyrate	T103	UMLS:C0142812
27694930	155	159	NaBu	T103	UMLS:C0142812
27694930	172	194	short-chain fatty acid	T103	UMLS:C0015691
27694930	196	200	SCFA	T103	UMLS:C0015691
27694930	232	253	anti-angiogenic agent	T103	UMLS:C0596087
27694930	257	263	tumour	T038	UMLS:C0027651
27694930	264	276	angiogenesis	T038	UMLS:C0302600
27694930	277	283	models	T038	UMLS:C0684309
27694930	338	342	NaBu	T103	UMLS:C0142812
27694930	361	368	healing	T038	UMLS:C0043240
27694930	372	378	tendon	T017	UMLS:C0039508
27694930	381	392	bone injury	T037	UMLS:C0561852
27694930	431	449	tissue remodelling	T038	UMLS:C1820201
27694930	517	521	NaBu	T103	UMLS:C0142812
27694930	528	536	in vitro	T062	UMLS:C1515653
27694930	541	548	in vivo	T082	UMLS:C1515655
27694930	549	555	assays	T058	UMLS:C0005507
27694930	562	574	angiogenesis	T038	UMLS:C0302600
27694930	669	673	NaBu	T103	UMLS:C0142812
27694930	702	712	UltraBraid	T074	UMLS:C0038969
27694930	715	719	NaBu	T103	UMLS:C0142812
27694930	720	726	suture	T074	UMLS:C0038969
27694930	731	745	pro-angiogenic	T038	UMLS:C0302600
27694930	781	790	migration	T038	UMLS:C1622501
27694930	792	806	tube formation	T038	UMLS:C2752214
27694930	811	824	cell invasion	T038	UMLS:C2699153
27694930	828	834	bovine	T204	UMLS:C3667982
27694930	835	841	aortic	T017	UMLS:C0003483
27694930	842	859	endothelial cells	T017	UMLS:C0225336
27694930	861	866	BAECs	T017	UMLS:C0225336
27694930	882	886	cell	T017	UMLS:C0007634
27694930	903	907	NaBu	T103	UMLS:C0142812
27694930	933	955	expression of proteins	T038	UMLS:C1171362
27694930	968	978	angiogenic	T038	UMLS:C0302600
27694930	979	994	cell signalling	T038	UMLS:C0037083
27694930	1006	1013	p-PKCβ1	T103	UMLS:C0257292
27694930	1015	1020	p-FAK	T103	UMLS:C0059239
27694930	1022	1028	p-ERK1	T103	UMLS:C0082529
27694930	1031	1032	2	T103	UMLS:C0170168
27694930	1034	1040	p-NFκβ	T103	UMLS:C0079904
27694930	1042	1049	p-PLCγ1	T103	UMLS:C0753837
27694930	1054	1062	p-VEGFR2	T103	UMLS:C0378796
27694930	1077	1087	inhibitors	T103	UMLS:C0243077
27694930	1096	1102	VEGFR2	T103	UMLS:C0378796
27694930	1107	1112	PKCβ1	T103	UMLS:C0257292
27694930	1125	1135	angiogenic	T038	UMLS:C0302600
27694930	1149	1156	in vivo	T082	UMLS:C1515655
27694930	1157	1163	assays	T058	UMLS:C0005507
27694930	1187	1191	NaBu	T103	UMLS:C0142812
27694930	1200	1218	neovascularization	T038	UMLS:C0027686
27694930	1222	1237	sponge implants	T074	UMLS:C0021102
27694930	1241	1245	mice	T204	UMLS:C0026809
27694930	1281	1288	vessels	T017	UMLS:C0005847
27694930	1293	1304	haemoglobin	T103	UMLS:C0019046
27694930	1322	1330	implants	T074	UMLS:C0021102
27694930	1395	1399	NaBu	T103	UMLS:C0142812
27694930	1444	1456	angiogenesis	T038	UMLS:C0302600
27694930	1462	1466	site	T082	UMLS:C1515974
27694930	1473	1484	vasculature	T017	UMLS:C3714653
27694930	1502	1509	healing	T038	UMLS:C0043240